Home › Juvenile Myelomonocytic Leukemia › Missouri › St. Louis
Juvenile Myelomonocytic Leukemia clinical trials in St. Louis, MO
3 studies for Juvenile Myelomonocytic Leukemia are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Therapeutic RSK1 Targeting in Myeloid Malignancies
RecruitingPhase 1
- Washington University School of Medicine, St Louis
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Cardinal Glennon Children's Medical Center, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital Saint Louis, St Louis
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
RecruitingPhase 1
- Washington University School of Medicine, St Louis
Juvenile Myelomonocytic Leukemia trials in other cities
- Minneapolis, MN4 studies
- Philadelphia, PA4 studies
- Seattle, WA3 studies
- Boston, MA3 studies
- Atlanta, GA3 studies
- Indianapolis, IN3 studies
- Ann Arbor, MI3 studies
- Chicago, IL3 studies
- Washington, DC3 studies
- San Francisco, CA3 studies
- Cincinnati, OH3 studies
- Memphis, TN3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer68 studies
- Breast Cancer63 studies
- Metastatic Cancer52 studies
- Cancer (all types)51 studies
- Colorectal Cancer51 studies
- Prostate Cancer45 studies
- Ovarian Cancer37 studies
- Lung Cancer37 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma32 studies
- Endometrial Cancer29 studies
- Multiple Myeloma26 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.